Yeast studies provide clue about controlling cholesterol levels
Washington, December 3 : Johns Hopkins researchers say that they have gained significant insights into the mechanism whereby a single-celled fungus regulates its version of cholesterol.
Writing about their work in the journal Cell Metabolism, the researchers say that their work may help better understand the target and action of cholesterol-lowering drugs taken daily by millions of people to stave off heart attacks and strokes.
Statin drugs inhibit an enzyme, HMG-CoA reductase, to lower blood cholesterol.
The researhcers say that a yeast called fission yeast, so named because they divide in the middle, is a good model for delving fast and deep into molecular details of how mammalian cells regulate HMG-CoA reductase.
They have thus far found that in these yeast, the regulatory protein Insig also regulates HMG-CoA reductase but does it differently.
According to them, Insig degrades this enzyme in mammals-essentially destroying it-while in fission yeast, Insig inactivates the enzyme simply by promoting the attachment of a phosphate.
"This is a surprising fundamental difference," says Peter J. Espenshade, a physiologist in the Department of Cell Biology and member of the Center for Metabolism and Obesity Research at the Johns Hopkins University School of Medicine.
He revealed that studies on fission yeast have so far shown that the protein Insig happily go about their business of manufacturing cholesterol in just the right amounts when all is well with cells.
As in humans, Insig in yeast limits cholesterol production by inactivating the enzyme HMG-CoA reductase.
However, how the yeast stopped synthesizing cholesterol was what surprised the scientists.
According to them, stressed fission yeast activated a protein called MAPK which, partnering with the protein Insig, attaches a phosphate onto the enzyme HMG-CoA reductase by a process known as phosphorylation and shuts down cholesterol manufacture.
The researchers say that their findings shed light on how a cell can change cholesterol production in response to a stressful environment.
"In this study, we not only learned something new about how Insig works and cholesterol biology, but we also found a rare example of a MAPK controlling a biosynthetic enzyme," Espenshade says.
By studying Insig control of HMG-CoA reductase in yeast, the researchers hope to inform improvements to the efficacy of statin and other cholesterol-lowering therapies.
ANI
-
Gold Silver Rate Today, 9 March 2026: City-Wise Prices, MCX Gold and Silver Ease Slightly After Rally -
Chinese Spy Ship Liaowang-1 Spotted Near Oman: Why Its Presence Near Oman Is Concerning For US Military -
Pune Gold Rate Today: Check Gold Prices For 18K, 22K, 24K in Pune -
Bangalore Gold Silver Rate Today, March 9, 2026: Gold and Silver Prices Fall as US Dollar Strengthens -
Who Is Nishant Kumar: Education, Personal Life and Possible Political Role -
Ind Vs NZ T20 World Cup Phalodi Satta Bazar Prediction: Know Who Will Win In India vs New Zealand Final -
Vijay-NDA Alliance On Cards? Pawan Kalyan Reportedly Reaches Out to TVK Chief -
Who Was Mojtaba Khamenei’s Wife Zahra Haddad-Adel and What Do We Know About Her? -
Trisha Hits Back at Parthiban: 'Crude Words Say More About the Speaker' -
India vs New Zealand T20 World Cup 2026 Final: Five Positive Signs Favouring India Before Title Clash -
IND vs NZ Final Live: When and Where to Watch India vs New Zealand T20 World Cup 2026 Title Clash -
Ind vs NZ T20 World Cup 2026: New Zealand Needs 256 Runs To Beat India And Win The World Cup












Click it and Unblock the Notifications